menu search

Algernon pharma receives notice of allowance from us patent and trademark office for repirinast

Algernon pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) said it has received a Notice of Allowance from th...

April 17, 2023, 8:16 am

Empower clinics signs clinical trials services deal with texas medical group

Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) has announced an agreement to develop a program for research and clinical trials services with a Dallas, T...

April 17, 2023, 7:47 am

Amneal pharmaceuticals' stock soars 14% premarket after company offers upbeat q1 guidance

Amneal pharmaceuticals Inc.'s stock AMRX, -2.16% soared 14% in premarket trade Monday, after the generi...

April 17, 2023, 6:53 am

Snbl to acquire satsuma pharmaceuticals

Transaction delivers immediate value and liquidity to Satsuma stockholders SNBL to acquire all outstanding shares of Satsuma for upfront cash consider...

April 16, 2023, 11:41 pm

Is arrowhead pharmaceuticals a buy now?

Arrowhead pharmaceuticals recently received a rating upgrade from SVB Financial and a price target that...

April 16, 2023, 5:21 am

Context therapeutics says ctim-76 abstract accepted for presentation at aacr annual meeting, will host webinar

Context Therapeutics (NASDAQ:CNTX) Inc announced that an abstract regarding its preclinical candidate, CTIM-76, a Claudin 6 x CD3 bispecific antibody,...

April 16, 2023, 3:01 am

1 "safe" stock to avoid and 1 to consider buying in april

In theory, the stock of companies that make generic drugs have the potential to be safe investments. Despite that, companies like Teva ...

April 15, 2023, 8:56 am

Does an fda fast track designation make regenxbio stock a buy now?

RegenxBio has several collaborations with other pharmaceutical companies. The company doesn't have its ...

April 15, 2023, 8:20 am

Abbvie: an investor's trifecta in transition

AbbVie is a pharmaceutical giant that is building out its portfolio to look nothing like it did a decad...

April 15, 2023, 7:35 am

Phathom pharmaceuticals, inc: company investigated by the portnoy law firm

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 14, 2023 (GLOBE NEWSWIRE) — The Portnoy...

April 14, 2023, 10:37 pm

Us charges el chapo sons, chinese businessmen with fentanyl trafficking

By Katharine Jackson and Luc Cohen (Reuters) – The United States has charged leaders of the Mexico-based Sinaloa Cartel with running a fentanyl traf...

April 14, 2023, 4:46 pm

Teva to host conference call to discuss first quarter 2023 financial results at 8 a.m. et on may 10, 2023

TEL AVIV, Israel--(BUSINESS WIRE)--Teva pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced ...

April 14, 2023, 4:15 pm

Quanta therapeutics presents data from kras inhibitor pipeline at annual aacr meeting in late-breaking research session

– Data highlight favorable preclinical profiles for two chemically-distinct allosteric, oral small molecule KRAS inhibitors with potent anti-tumor a...

April 14, 2023, 4:05 pm

Ocular therapeutix™ to present pre-clinical and clinical data at the 2023 association for research in vision and ophthalmology (arvo) annual meeting

BEDFORD, Mass., April 14, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical...

April 14, 2023, 4:01 pm

Theratechnologies stock price continues higher on company guidance

Theratechnologies (TSX:TH) Inc shares continued to advance Friday, up 12% to $1.29 following a 10% gain on Thursday, after the bio...

April 14, 2023, 2:33 pm

Aadi bioscience to present multiple posters on nab-sirolimus at the 2023 american association for cancer research (aacr) annual meeting

LOS ANGELES , April 14, 2023 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharm...

April 14, 2023, 1:09 pm

Amyotrophic lateral sclerosis treatment market sales to reach us$ 1021 million in 2032 | cagr of 5.6%

Investment in research and development by pharmaceutical companies is expected to propel the growth of ...

April 14, 2023, 12:50 pm

Global methenamine hippurate tablets market size is anticipated to acquire 6.51% billion by 2030 with cagr of 6.51% | pharmaceuticals industry analysis

[214 + Pages Research Study] According to a market research study published by Zion Market Research, the demand analysis of Global Methenamine Hippura...

April 14, 2023, 12:06 pm

Spero therapeutics to present data at the 33rd european congress of clinical microbiology and infectious diseases

CAMBRIDGE, Mass., April 14, 2023 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage bio...

April 14, 2023, 12:05 pm

Achieve life sciences to present at life science innovation northwest 2023 conference

SEATTLE and VANCOUVER, British Columbia, April 14, 2023 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage ...

April 14, 2023, 12:00 pm


Search within

Pages Search Results: